Personal information

Other IDs

Scopus Author ID: 56902365000

Activities

Collapse all

Employment (1)

Azienda Ospedaliero-Universitaria di Parma: Parma, PARMA, IT

Employment
Source: Self-asserted source
Francesca Negri

Works (47)

Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1132564
EID:

2-s2.0-85150192307

Part of ISSN: 2234943X
Contributors: Negri, F.; Bottarelli, L.; Pedrazzi, G.; Maddalo, M.; Leo, L.; Milanese, G.; Sala, R.; Lecchini, M.; Campanini, N.; Bozzetti, C. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Unconsolidated Results of Consolidation Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Journal of Clinical Oncology
2022 | Journal article
DOI: 10.1200/JCO.22.00923
EID:

2-s2.0-85142941042

Part of ISSN: 15277755 0732183X
Contributors: Negri, F.; Aschele, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

KRAS: A Druggable Target in Colon Cancer Patients

International Journal of Molecular Sciences
2022-04 | Journal article | Author
DOI: 10.3390/ijms23084120
Contributors: Francesca Negri; Lorena Bottarelli; Gian Luigi de’ Angelis; Letizia Gnetti
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Donafenib in Chinese patients with advanced hepatocellular carcinoma (HCC): Really a new standard of care, or should we change paradigm for drug development in HCC?

Oncology Reviews
2021 | Journal article
DOI: 10.4081/oncol.2021.564
EID:

2-s2.0-85118680716

Part of ISSN: 19705565 19705557
Contributors: Negri, F.; Porta, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research

Translational Oncology
2021 | Journal article
DOI: 10.1016/j.tranon.2021.101153
EID:

2-s2.0-85107942314

Part of ISSN: 19365233
Contributors: Negri, F.; Missale, G.; Antoni, A.D.; Porta, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial

European Journal of Cancer
2021 | Journal article
DOI: 10.1016/j.ejca.2021.02.023
EID:

2-s2.0-85105007363

Part of ISSN: 18790852 09598049
Contributors: Cascinu, S.; Berardi, R.; Bianco, R.; Bilancia, D.; Zaniboni, A.; Ferrari, D.; Mosconi, S.; Spallanzani, A.; Cavanna, L.; Leo, S. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Sorafenib and hepatocellular carcinoma: Is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?

Future Oncology
2021 | Journal article
DOI: 10.2217/fon-2021-0083
EID:

2-s2.0-85114372527

Part of ISSN: 17448301 14796694
Contributors: Negri, F.; Gnetti, L.; Pedrazzi, G.; Silini, E.M.; Porta, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes

International Journal of Molecular Sciences
2021-05 | Journal article | Author
DOI: 10.3390/ijms22105246
Contributors: Federica Gaiani; Federica Marchesi; Francesca Negri; Luana Greco; Alberto Malesci; Gian Luigi de’Angelis; Luigi Laghi
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients

Journal of Cancer Research and Clinical Oncology
2020 | Journal article
DOI: 10.1007/s00432-019-03077-w
EID:

2-s2.0-85074856602

Part of ISSN: 14321335 01715216
Contributors: Catalano, V.; Bergamo, F.; Cremolini, C.; Vincenzi, B.; Negri, F.; Giordani, P.; Alessandroni, P.; Intini, R.; Stragliotto, S.; Rossini, D. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

ROS1 rearrangements are uncommon in biliary tract cancers

Oncology Letters
2020 | Journal article
DOI: 10.3892/OL.2020.12179
EID:

2-s2.0-85093829996

Part of ISSN: 17921082 17921074
Contributors: Mazzoni, F.; Petreni, P.; Vasile, E.; Panebianco, M.; Casadei‑Gardini, A.; Negri, F.; Lunghi, A.; Pillozzi, S.; Vivaldi, C.; Gervasi, E. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer

International Journal of Molecular Sciences
2020-12 | Journal article | Author
DOI: 10.3390/ijms21249680
Contributors: Luigi Laghi; Francesca Negri; Federica Gaiani; Tommaso Cavalleri; Fabio Grizzi; Gian Luigi de’ Angelis; Alberto Malesci
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

European Journal of Cancer
2019 | Journal article
DOI: 10.1016/j.ejca.2019.06.008
EID:

2-s2.0-85069554648

Part of ISSN: 18790852 09598049
Contributors: Loupakis, F.; Intini, R.; Cremolini, C.; Orlandi, A.; Sartore-Bianchi, A.; Pietrantonio, F.; Pella, N.; Spallanzani, A.; Dell'Aquila, E.; Scartozzi, M. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer

Oncology Reports
2019 | Journal article
DOI: 10.3892/or.2019.7349
EID:

2-s2.0-85074527296

Part of ISSN: 17912431 1021335X
Contributors: Negri, F.; Bozzetti, C.; Pedrazzi, G.; Azzoni, C.; Bottarelli, L.; Squadrilli, A.; Lagrasta, C.; Tamagnini, I.; Bisagni, A.; Ragazzi, M. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series

Scientific Reports
2019 | Journal article
DOI: 10.1038/s41598-019-40096-6
EID:

2-s2.0-85062633988

Part of ISSN: 20452322
Contributors: Negri, F.; De Giorgi, A.; Gilli, A.; Azzoni, C.; Bottarelli, L.; Gnetti, L.; Goldoni, M.; Manotti, L.; Sgargi, P.; Michiara, M. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Medical Treatment of Advanced Hepatocellular Carcinoma Patients: The Issue Is Not the Right Drug, but the Right Patient

Hepatology
2019 | Journal article
DOI: 10.1002/hep.30521
EID:

2-s2.0-85062987071

Part of ISSN: 15273350 02709139
Contributors: Porta, C.; Broglia, C.; Negri, F.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Microsatellite instability in colorectal cancer

Acta Biomedica
2018 | Journal article
DOI: 10.23750/abm.v89i9-S.7960
EID:

2-s2.0-85058735244

Part of ISSN: 25316745 03924203
Contributors: De’angelis, G.L.; Bottarelli, L.; Azzoni, C.; De’angelis, N.; Leandro, G.; Di Mario, F.; Gaiani, F.; Negri, F.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol

Tumori
2018 | Journal article
DOI: 10.5301/tj.5000704
EID:

2-s2.0-85054987294

Part of ISSN: 20382529 03008916
Contributors: Gardini, A.C.; Faloppi, L.; Aprile, G.; Brunetti, O.; Caparello, C.; Corbelli, J.; Chessa, L.; Bruno, D.; Ercolani, G.; Leonetti, A. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy

Acta Biomedica
2018 | Journal article
DOI: 10.23750/abm.v89i9-S.7881
EID:

2-s2.0-85058772539

Part of ISSN: 25316745 03924203
Contributors: Bottarelli, L.; De’angelis, G.L.; Azzoni, C.; Di Mario, F.; De’ Angelis, N.; Leandro, G.; Fornaroli, F.; Gaiani, F.; Negri, F.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

The Lancet Oncology
2018 | Journal article
DOI: 10.1016/S1470-2045(18)30146-3
EID:

2-s2.0-85044869480

Part of ISSN: 14745488 14702045
Contributors: Rimassa, L.; Assenat, E.; Peck-Radosavljevic, M.; Pracht, M.; Zagonel, V.; Mathurin, P.; Rota Caremoli, E.; Porta, C.; Daniele, B.; Bolondi, L. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Fingerprint Change: Not Visible, But Tangible

Journal of Forensic Sciences
2017 | Journal article
DOI: 10.1111/1556-4029.13422
EID:

2-s2.0-85020435733

Part of ISSN: 15564029 00221198
Contributors: Negri, F.V.; De Giorgi, A.; Bozzetti, C.; Squadrilli, A.; Petronini, P.G.; Leonardi, F.; Bisogno, L.; Garofano, L.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Immunotherapy for colorectal cancer: where are we heading?

Expert Opinion on Biological Therapy
2017 | Journal article
DOI: 10.1080/14712598.2017.1315405
EID:

2-s2.0-85019084692

Part of ISSN: 17447682 14712598
Contributors: Basile, D.; Garattini, S.K.; Bonotto, M.; Ongaro, E.; Casagrande, M.; Cattaneo, M.; Fanotto, V.; De Carlo, E.; Loupakis, F.; Urbano, F. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Molecular classifications of gastric cancers: Novel insights and possible future applications

World Journal of Gastrointestinal Oncology
2017 | Journal article
DOI: 10.4251/wjgo.v9.i5.194
EID:

2-s2.0-85028408934

Part of ISSN: 19485204
Contributors: Garattini, S.K.; Basile, D.; Cattaneo, M.; Fanotto, V.; Ongaro, E.; Bonotto, M.; Negri, F.V.; Berenato, R.; Ermacora, P.; Cardellino, G.G. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival

Journal of Thoracic Disease
2017 | Journal article
DOI: 10.21037/jtd.2017.07.100
EID:

2-s2.0-85030977054

Part of ISSN: 20776624 20721439
Contributors: Ampollini, L.; Gnetti, L.; Goldoni, M.; Viani, L.; Faedda, E.; Campanini, N.; Caruana, P.; Crafa, P.; Negri, F.; Pucci, F. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?

Critical Reviews in Oncology/Hematology
2017 | Journal article
DOI: 10.1016/j.critrevonc.2017.03.025
EID:

2-s2.0-85024834271

Part of ISSN: 18790461 10408428
Contributors: Aprile, G.; Negri, F.V.; Giuliani, F.; De Carlo, E.; Melisi, D.; Simionato, F.; Silvestris, N.; Brunetti, O.; Leone, F.; Marino, D. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

FCGR, cetuximab, and colorectal cancer survival-letter

Clinical Cancer Research
2016 | Journal article
DOI: 10.1158/1078-0432.CCR-16-1470
EID:

2-s2.0-84990990405

Part of ISSN: 15573265 10780432
Contributors: Negri, F.V.; Boggiani, D.; Rimanti, A.; Musolino, A.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.11264
EID:

2-s2.0-84995403741

Part of ISSN: 19492553
Contributors: Fanotto, V.; Ongaro, E.; Rihawi, K.; Avallone, A.; Silvestris, N.; Fornaro, L.; Vasile, E.; Antonuzzo, L.; Leone, F.; Rosati, G. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.11565
EID:

2-s2.0-84993997499

Part of ISSN: 19492553
Contributors: Gardini, A.C.; Scarpi, E.; Faloppi, L.; Scartozzi, M.; Silvestris, N.; Santini, D.; de Stefano, G.; Marisi, G.; Negri, F.V.; Foschi, F.G. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Second-line angiogenesis inhibition in metastatic colorectal cancer patients: Straightforward or overcrowded?

Critical Reviews in Oncology/Hematology
2016 | Journal article
DOI: 10.1016/j.critrevonc.2016.02.005
EID:

2-s2.0-84960452031

Part of ISSN: 18790461 10408428
Contributors: Giampieri, R.; Caporale, M.; Pietrantonio, F.; De Braud, F.; Negri, F.V.; Giuliani, F.; Pusceddu, V.; Demurtas, L.; Restivo, A.; Fontanella, C. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment

Liver International
2015 | Journal article
DOI: 10.1111/liv.12778
EID:

2-s2.0-84937973752

Part of ISSN: 14783231 14783223
Contributors: Negri, F.V.; Dal Bello, B.; Porta, C.; Campanini, N.; Rossi, S.; Tinelli, C.; Poggi, G.; Missale, G.; Fanello, S.; Salvagni, S. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer

Future Oncology
2015 | Journal article
DOI: 10.2217/fon.15.218
EID:

2-s2.0-84971667778

Part of ISSN: 17448301 14796694
Contributors: Negri, F.V.; Crafa, P.; Pedrazzi, G.; Bozzetti, C.; Lagrasta, C.; Gardini, G.; Tamagnini, I.; Bisagni, A.; Azzoni, C.; Bottarelli, L. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Urea-based cream to prevent sorafenib-induced hand-and-foot skin reaction: Which evidence?

Journal of Clinical Oncology
2015 | Journal article
DOI: 10.1200/JCO.2015.61.6417
EID:

2-s2.0-84944230318

Part of ISSN: 15277755 0732183X
Contributors: Negri, F.V.; Porta, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy

Pharmacogenomics Journal
2014 | Journal article
DOI: 10.1038/tpj.2012.54
EID:

2-s2.0-84893651406

Part of ISSN: 1470269X 14731150
Contributors: Negri, F.V.; Musolino, A.; Naldi, N.; Bortesi, B.; Missale, G.; Laccabue, D.; Zerbini, A.; Camisa, R.; Chernyschova, N.; Bisagni, G. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Epidermal growth factor receptor and Kras gene expression: Reliability of mutational analysis on cytological samples

Diagnostic Cytopathology
2013 | Journal article
DOI: 10.1002/dc.22905
EID:

2-s2.0-84879421859

Part of ISSN: 87551039 10970339
Contributors: Bozzetti, C.; Negri, F.V.; Azzoni, C.; Naldi, N.; Nizzoli, R.; Bortesi, B.; Zobbi, V.; Bottarelli, L.; Tiseo, M.; Silini, E.M. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer

Anticancer Research
2013 | Journal article
EID:

2-s2.0-84875900868

Part of ISSN: 02507005
Contributors: Fontana, E.; Pucci, F.; Camisa, R.; Bui, S.; Galdy, S.; Leonardi, F.; Negri, F.V.; Anselmi, E.; Losardo, P.L.; Roncoroni, L. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Thymidylate synthase, topoisomerase-1 and microsatellite instability: Relationship with outcome in mucinous colorectal cancer treated with fluorouracil

Anticancer Research
2013 | Journal article
EID:

2-s2.0-84891358954

Part of ISSN: 02507005
Contributors: Negri, F.V.; Azzoni, C.; Bottarelli, L.; Campanini, N.; Mandolesi, A.; Wotherspoon, A.; Cunningham, D.; Scartozzi, M.; Cascinu, S.; Tinelli, C. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

British Journal of Cancer
2011 | Journal article
DOI: 10.1038/bjc.2011.121
EID:

2-s2.0-79955468866

Part of ISSN: 15321827 00070920
Contributors: Bozzetti, C.; Negri, F.V.; Lagrasta, C.A.; Crafa, P.; Bassano, C.; Tamagnini, I.; Gardini, G.; Nizzoli, R.; Leonardi, F.; Gasparro, D. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Erratum: Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma (British Journal of Cancer (2011) 104 (1372-1376) DOI: 10.1038/bjc.2011.121)

British Journal of Cancer
2011 | Journal article
DOI: 10.1038/bjc.2011.208
EID:

2-s2.0-79958150034

Part of ISSN: 00070920 15321827
Contributors: Bozzetti, C.; Negri, F.V.; Lagrasta, C.A.; Crafa, P.; Bassano, C.; Tamagnini, I.; Gardini, G.; Nizzoli, R.; Leonardi, F.; Gasparro, D. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

HER-2 discordance between primary gastric carcinoma and paired lymph node metastasis

Human Pathology
2011 | Journal article
DOI: 10.1016/j.humpath.2011.01.016
EID:

2-s2.0-79956150965

Part of ISSN: 00468177 15328392
Contributors: Negri, F.V.; Bozzetti, C.; Ardizzoni, A.; Lagrasta, C.; Crafa, P.; Silini, E.M.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Reliability of K-ras mutational analysis on cytological samples from metastatic colorectal cancer

Pathologica
2011 | Journal article
EID:

2-s2.0-80053256064

Part of ISSN: 00312983
Contributors: Bozzeti, C.; Negri, F.V.; Naldi, N.; Nizzoli, R.; Bortesi, B.; Zobi, V.; Azzoni, C.; Silini, E.M.; Ardizzoni, A.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

PTEN status in advanced colorectal cancer treated with cetuximab

British Journal of Cancer
2010 | Journal article
DOI: 10.1038/sj.bjc.6605471
EID:

2-s2.0-74249093155

Part of ISSN: 00070920 15321827
Contributors: Negri, F.V.; Bozzetti, C.; Lagrasta, C.A.; Crafa, P.; Bonasoni, M.P.; Camisa, R.; Pedrazzi, G.; Ardizzoni, A.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: A fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

BMC Cancer
2009 | Journal article
DOI: 10.1186/1471-2407-9-303
EID:

2-s2.0-70049091759

Part of ISSN: 14712407
Contributors: Scartozzi, M.; Bearzi, I.; Mandolesi, A.; Pierantoni, C.; Loupakis, F.; Zaniboni, A.; Negri, F.; Quadri, A.; Zorzi, F.; Galizia, E. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy

British Journal of Cancer
2008 | Journal article
DOI: 10.1038/sj.bjc.6604131
EID:

2-s2.0-38049028764

Part of ISSN: 00070920 15321827
Contributors: Negri, F.V.; Campanini, N.; Camisa, R.; Pucci, F.; Bui, S.; Ceccon, G.; Martinelli, R.; Fumagalli, M.; Losardo, P.L.; Crafa, P. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: Outcome study in clinical practice

Journal of Chemotherapy
2008 | Journal article
DOI: 10.1179/joc.2008.20.3.374
EID:

2-s2.0-47349115226

Part of ISSN: 1120009X
Contributors: Lelli, G.; Cataldo, S.; Carandina, I.; Urbini, B.; Bonetti, F.; Marzola, M.; Biasco, G.; Pantaleo, M.A.; Brandes, A.; Calandri, C. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer

Annals of Oncology
2005 | Journal article
DOI: 10.1093/annonc/mdi244
EID:

2-s2.0-23844521660

Part of ISSN: 09237534
Contributors: Negri, F.V.; Wotherspoon, A.; Cunningham, D.; Norman, A.R.; Chong, G.; Ross, P.J.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

A retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: The development of a preoperative chemotherapy strategy

Clinical Colorectal Cancer
2004 | Journal article
DOI: 10.3816/CCC.2004.n.013
EID:

2-s2.0-4444375263

Part of ISSN: 15330028
Contributors: Negri, F.; Musolino, A.; Cunningham, D.; Pastorino, U.; Ladas, G.; Norman, A.R.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Trends in cancer mortality in Mexico, 1970-1999

Annals of Oncology
2004 | Journal article
DOI: 10.1093/annonc/mdh424
EID:

2-s2.0-9444277943

Part of ISSN: 09237534
Contributors: Malvezzi, M.; Bosetti, C.; Chatenoud, L.; Rodríguez, T.; Levi, F.; Negri, F.; La Vecchia, C.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma

Cancer
2003 | Journal article
DOI: 10.1002/cncr.11731
EID:

2-s2.0-0141891477

Part of ISSN: 0008543X
Contributors: Bozzetti, C.; Personeni, N.; Nizzoli, R.; Guazzi, A.; Flora, M.; Bassano, C.; Negri, F.; Martella, E.; Naldi, N.; Franciosi, V. et al.
Source: Self-asserted source
Francesca Negri via Scopus - Elsevier
grade
Preferred source (of 2)‎

Peer review (1 review for 1 publication/grant)

Review activity for British journal of cancer. (1)
How many people are using ORCID?